Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz
14
2
2
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
7.1%
1 terminated/withdrawn out of 14 trials
88.9%
+2.4% vs industry average
29%
4 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Implementability and Effectiveness of the Safety Planning Intervention for Suicidal Behavior
Role: collaborator
Analysis of Musical and Voice Skills in Children and Adult Cochlear Implant Users
Role: lead
Anatomy-based Fitting in Cochear Implant Users
Role: lead
Sarco-COVID Study: Measuring the Loss of Skeletal Muscle Mass in the Hospitalized Patient With the Diagnosis of COVID-19
Role: lead
Renal Colic Fast Track Pathway in the Emergency Department.
Role: lead
Dobutamine in the Treatment of Haemodynamic Insufficiency in the Immediate Postnatal Period
Role: lead
Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells for the Induction of Remission in Ulcerative Colitis
Role: collaborator
Echocardiographically Guided Versus Standard Ibuprofen Treatment for Patent Ductus Arteriosus
Role: lead
Two Inodilators Postsurgery in Neonates
Role: lead
Allogenic Stem Cells Derived From Lipoaspirates for the Treatment of Recto-vaginal Fistulas Associated to Crohn's Disease (ALOREVA)
Role: lead
Conjugated Linoleic Acid (1:1 Isomer Mixture) Intake in Overweight People
Role: lead
Folic Acid Supplementation in Eating Disorder
Role: lead
Autologous Mesenchymal Stem Cells vs. Chondrocytes for the Repair of Chondral Knee Defects
Role: lead
Bread in Overweight/Obesity Treatment
Role: lead
All 14 trials loaded